UNSPSC 51361805: Metomidate

This classification denotes a sedative and hypnotic with the molecular formula C13H14N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z18ZYL8Y51, chemically known as 1h-imidazole-5-carboxylic acid, 1- (1-phenylethyl)-, methyl ester, monohydrochloride but generally known as metomidate, which bears US NIH Compound Identifier 21474. European Medicines Agency schedules Metomidate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08907MIG.

UNSPSC 51361805 Metomidate is a Commodity code representing pharmaceutical and medical products purchased by state and local health authorities. The recent solicitation activity under this code reflects procurement of naloxone and drug deactivation systems for community health initiatives, though the code's nominal scope (metomidate, a sedative pharmaceutical) does not fully align with the drug-response and harm-reduction equipment actually being bought. State and local health departments and county community health agencies are the primary issuing bodies, with naloxone and safe drug deactivation systems serving opioid-overdose response and public health support in jurisdictions managing substance-use crises.

Seminole County, Florida posted an IFB (Invitation for Bid) in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford and a response deadline of July 26, 2023. The contract carries a two-year initial term with a one-year renewal option, requires E-Verify compliance and drug-free workplace certification, and may be FEMA-funded, introducing federal environmental compliance requirements. The procurement shows limited recent activity; the single record in the block represents the only documented state or local solicitation under this code, with no evidence of additional opportunities across other jurisdictions or states.